» Articles » PMID: 22805317

Protective Role of Neuropeptide Y Y₂ Receptors in Cell Death and Microglial Response Following Methamphetamine Injury

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 2012 Jul 19
PMID 22805317
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

It has been reported that the hippocampus is very susceptible to methamphetamine (METH) and that neuropeptide Y (NPY) is an important neuroprotective agent against hippocampal excitotoxicity. However, there is very little information regarding the role of the NPYergic system in this brain region under conditions of METH toxicity. To clarify this issue, we investigated the role of NPY and its receptors against METH-induced neuronal cell death in hippocampal organotypic slice cultures. Our data show that NPY (1 μm) is neuroprotective in DG, CA3 and CA1 subregions via Y(2) receptors. Moreover, the selective activation of Y(1) receptors (1 μm [Leu(31) ,Pro(34) ]NPY) partially prevented the toxicity induced by METH in DG and CA3 subfields, but completely blocked its toxicity in the CA1 pyramidal cell layer. Regarding Y(2) receptors, its activation (300 nm NPY13-36) completely prevented METH-induced toxicity in all subregions analysed, which involved changes in levels of pro- and anti-apoptotic proteins Bcl-2 and Bax, respectively. Besides neuronal cell death, we also showed that METH triggers a microglial response in the mouse hippocampus which was attenuated by Y(2) receptor activation. To better clarify the effect of METH and the NPY system on microglial cells, we further used the N9 microglial cell line. We found that both NPY and the Y(2) receptor agonist were able to protect microglia against METH-induced cell death. Overall, our data demonstrate that METH is toxic to both neurons and microglial cells, and that NPY, mainly via Y(2) receptors, has an important protective role against METH-induced cell death and microgliosis.

Citing Articles

Peptide discovery across the spectrum of neuroinflammation; microglia and astrocyte phenotypical targeting, mediation, and mechanistic understanding.

Benita B, Koss K Front Mol Neurosci. 2024; 17:1443985.

PMID: 39634607 PMC: 11616451. DOI: 10.3389/fnmol.2024.1443985.


Role of Microglia in Psychostimulant Addiction.

da Silva M, Iglesias L, Candelario-Jalil E, Khoshbouei H, Moreira F, de Oliveira A Curr Neuropharmacol. 2022; 21(2):235-259.

PMID: 36503452 PMC: 10190137. DOI: 10.2174/1570159X21666221208142151.


Neuroendocrine regulations in tissue-specific immunity: From mechanism to applications in tumor.

Liu S, Li B, Li J, Sun S, Sun S, Wu Q Front Cell Dev Biol. 2022; 10:896147.

PMID: 36072337 PMC: 9442449. DOI: 10.3389/fcell.2022.896147.


Sleep Disturbance and Alzheimer's Disease: The Glial Connection.

Sunkaria A, Bhardwaj S Neurochem Res. 2022; 47(7):1799-1815.

PMID: 35303225 DOI: 10.1007/s11064-022-03578-0.


Regulation of neuropeptide Y in body microenvironments and its potential application in therapies: a review.

Zhang Y, Liu C, Chen W, Shi Y, Wang C, Lin S Cell Biosci. 2021; 11(1):151.

PMID: 34344469 PMC: 8330085. DOI: 10.1186/s13578-021-00657-7.